首页>
外国专利>
BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION
BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION
展开▼
机译:多发性骨髓瘤发展和进步的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for the prognosis of Symptomatic Multiple Myeloma (MM) and/or to monitor the response and/or the efficacy of a MM therapy comprising detecting and/or quantifying at least one marker, to relative kit and uses thereof and to relative microarray and use thereof. Markers include C3f peptide or a fragment thereof and/or other metabolites.
展开▼